127 related articles for article (PubMed ID: 5164436)
1. [Effects of thiothixene on schizophrenic symptoms in a long-term therapeutic scheme. Comparative study with butyrophenone derivative].
Vianna Filho U; Muniz AF; Terra SO; Bueno JR
J Bras Psiquiatr; 1971; 20(3):193-204. PubMed ID: 5164436
[No Abstract] [Full Text] [Related]
2. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
Engelhardt DM; Rudorfer L; Rosen B
J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
Abuzzahab FS; Zimmerman RL
J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
[TBL] [Abstract][Full Text] [Related]
4. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
Kelwala S; Ban TA; Berney SA; Wilson WH
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
Slotnick VB
J Clin Psychiatry; 1980 Mar; 41(3):105-6. PubMed ID: 7354016
[No Abstract] [Full Text] [Related]
6. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
Balon R; Berchou R; Zethelius M
Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of loxapine succinate in acute schizophrenia: a comparative study with thiothixene.
van der Velde CD; Kiltie H
Curr Ther Res Clin Exp; 1975 Jan; 17(1):1-12. PubMed ID: 806422
[No Abstract] [Full Text] [Related]
8. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
[No Abstract] [Full Text] [Related]
9. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
Ruiz-Navarro JF; Vergara L; Deutsch M
Psychopharmacol Bull; 1976 Jan; 12(1):38-9. PubMed ID: 1108083
[No Abstract] [Full Text] [Related]
10. Response to antipsychotic medication: the doctor's and the consumer's view.
Van Putten T; May PR; Marder SR
Am J Psychiatry; 1984 Jan; 141(1):16-9. PubMed ID: 6691455
[TBL] [Abstract][Full Text] [Related]
11. Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients.
Ahmad SH; Hasan KZ
J Pak Med Assoc; 1977 Apr; 27(4):313-6. PubMed ID: 411951
[TBL] [Abstract][Full Text] [Related]
12. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
[No Abstract] [Full Text] [Related]
13. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene.
Kim DY; Hollister LE
J Clin Psychopharmacol; 1984 Feb; 4(1):32-5. PubMed ID: 6693581
[TBL] [Abstract][Full Text] [Related]
14. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
Hardeman WJ; Bakker SJ
Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
[No Abstract] [Full Text] [Related]
15. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
Howard JS
Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
[No Abstract] [Full Text] [Related]
16. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.
Bartlett EJ; Wolkin A; Brodie JD; Laska EM; Wolf AP; Sanfilipo M
Psychiatry Res; 1991 Oct; 40(2):115-24. PubMed ID: 1763142
[TBL] [Abstract][Full Text] [Related]
17. Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia.
Tandon R; Goldman RS; Goodson J; Greden JF
Biol Psychiatry; 1990 Jun; 27(12):1323-6. PubMed ID: 2364120
[No Abstract] [Full Text] [Related]
18. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
Villeneuve C; Ananth JV; Ban TA; Lehmann HE
Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
[No Abstract] [Full Text] [Related]
19. Drug-induced dystonia.
Swett C
Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
